These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 22241448

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S, Mundorf TK, Stewart JA, Stewart WC.
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Survey of current status of adverse ocular reactions to paclitaxel and a retrospective analysis for aiding in early detection of adverse reactions].
    Noguchi Y, Nishimura R, Kawara H, Omori K, Matsumoto K, Tokuyama Y, Uchiyama K, Shimizu Y.
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):819-22. PubMed ID: 23863667
    [Abstract] [Full Text] [Related]

  • 8. The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.
    Keltner JL, Johnson CA, Anderson DR, Levine RA, Fan J, Cello KE, Quigley HA, Budenz DL, Parrish RK, Kass MA, Gordon MO, Ocular Hypertension Treatment Study Group.
    Ophthalmology; 2006 Sep; 113(9):1603-12. PubMed ID: 16949445
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinically important ocular reactions to systemic drug therapy.
    Rennie IG.
    Drug Saf; 1993 Sep; 9(3):196-211. PubMed ID: 8240725
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Toxic optic neuropathy associated with ethambutol: implications for current therapy.
    Russo PA, Chaglasian MA.
    J Am Optom Assoc; 1994 May; 65(5):332-8. PubMed ID: 8071504
    [Abstract] [Full Text] [Related]

  • 18. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B, Demirel S, Zhang X, Hood DC, Patterson E, Jamil A, Mansberger SL, Cioffi GA, Johnson CA.
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [Abstract] [Full Text] [Related]

  • 19. Hyperbaric oxygen therapy and the eye.
    Butler FK, Hagan C, Murphy-Lavoie H.
    Undersea Hyperb Med; 2008 Mar; 35(5):333-87. PubMed ID: 19024664
    [Abstract] [Full Text] [Related]

  • 20. Toxic ocular effects of ethambutol.
    Kahana LM.
    CMAJ; 1987 Aug 01; 137(3):213-6. PubMed ID: 3607664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.